193 related articles for article (PubMed ID: 30187220)
1. Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.
Stahl JM; Qian JM; Tien CJ; Carlson DJ; Chen Z; Ratner ES; Park HS; Damast S
Support Care Cancer; 2019 Apr; 27(4):1425-1433. PubMed ID: 30187220
[TBL] [Abstract][Full Text] [Related]
2. The impact of vaginal dilator use on vaginal stenosis and sexual quality of life in women treated with adjuvant radiotherapy for endometrial cancer.
Akbaba S; Oelmann-Avendano JT; Krug D; Arians N; Bostel T; Hoerner-Rieber J; Nicolay NH; Debus J; Lindel K; Foerster R
Strahlenther Onkol; 2019 Oct; 195(10):902-912. PubMed ID: 30997541
[TBL] [Abstract][Full Text] [Related]
3. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.
Park HS; Ratner ES; Lucarelli L; Polizzi S; Higgins SA; Damast S
Brachytherapy; 2015; 14(4):464-70. PubMed ID: 25887343
[TBL] [Abstract][Full Text] [Related]
4. Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer.
Bahng AY; Dagan A; Bruner DW; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):667-73. PubMed ID: 21300451
[TBL] [Abstract][Full Text] [Related]
5. Can an educational intervention improve compliance with vaginal dilator use in patients treated with radiation for a gynecological malignancy?
Brand AH; Do V; Stenlake A
Int J Gynecol Cancer; 2012 Jun; 22(5):897-904. PubMed ID: 22552831
[TBL] [Abstract][Full Text] [Related]
6. Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trial.
Martins J; Vaz AF; Grion RC; Costa-Paiva L; Baccaro LF
BMC Cancer; 2021 Jun; 21(1):682. PubMed ID: 34112100
[TBL] [Abstract][Full Text] [Related]
7. Qualitative accounts of patients' determinants of vaginal dilator use after pelvic radiotherapy.
Bakker RM; Vermeer WM; Creutzberg CL; Mens JW; Nout RA; Ter Kuile MM
J Sex Med; 2015 Mar; 12(3):764-73. PubMed ID: 25424559
[TBL] [Abstract][Full Text] [Related]
8. Dilator Use After Vaginal Brachytherapy for Endometrial Cancer: A Randomized Feasibility and Adherence Study.
Hanlon A; Small W; Strauss J; Lin LL; Hanisch L; Huang L; Bai J; Wells J; Bruner DW
Cancer Nurs; 2018; 41(3):200-209. PubMed ID: 28437283
[TBL] [Abstract][Full Text] [Related]
9. Vaginal dilator use to promote sexual wellbeing after radiotherapy in gynecological cancer survivors.
Charatsi D; Vanakara P; Evaggelopoulou E; Simopoulou F; Korfias D; Daponte A; Kyrgias G; Tolia M
Medicine (Baltimore); 2022 Jan; 101(4):e28705. PubMed ID: 35089231
[TBL] [Abstract][Full Text] [Related]
10. From "sex toy" to intrusive imposition: a qualitative examination of women's experiences with vaginal dilator use following treatment for gynecological cancer.
Cullen K; Fergus K; Dasgupta T; Fitch M; Doyle C; Adams L
J Sex Med; 2012 Apr; 9(4):1162-73. PubMed ID: 22304701
[TBL] [Abstract][Full Text] [Related]
11. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
12. Prevention of vaginal stenosis in patients following vaginal brachytherapy.
Decruze SB; Guthrie D; Magnani R
Clin Oncol (R Coll Radiol); 1999; 11(1):46-8. PubMed ID: 10194586
[TBL] [Abstract][Full Text] [Related]
13. Impact of different adjuvant radiotherapy modalities on women with early-stage intermediate- to high-risk endometrial cancer.
Jin M; Hou X; Sun X; Zhang Y; Hu K; Zhang F
Int J Gynecol Cancer; 2019 Oct; 29(8):1264-1270. PubMed ID: 31320487
[TBL] [Abstract][Full Text] [Related]
14. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
[TBL] [Abstract][Full Text] [Related]
15. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Predictors of Radiation-Induced Vaginal Stenosis After Pelvic Radiation Therapy for Rectal and Anal Cancer.
Son CH; Law E; Oh JH; Apte AP; Yang TJ; Riedel E; Wu AJ; Deasy JO; Goodman KA
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):548-54. PubMed ID: 25936810
[TBL] [Abstract][Full Text] [Related]
17. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
[TBL] [Abstract][Full Text] [Related]
18. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.
Bruner DW; Lanciano R; Keegan M; Corn B; Martin E; Hanks GE
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):825-30. PubMed ID: 8244811
[TBL] [Abstract][Full Text] [Related]
19. Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas.
Hasbini A; Haie-Meder C; Morice P; Chirat E; Duvillard P; Lhommé C; Delapierre M; Gerbaulet A
Radiother Oncol; 2002 Oct; 65(1):23-8. PubMed ID: 12413671
[TBL] [Abstract][Full Text] [Related]
20. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
